The specific small-molecule inhibitor of ferroptosis suppressor protein 1 (iFSP1) not only effectively induces ferroptosis and reduces tumor burden in HCC models but also significantly reshapes the tumor immune microenvironment via FSP1-dependent mechanisms [43]. This evidence concerns the gene AIFM2 and hepatocellular carcinoma.